Startseite>>Signaling Pathways>> Neuroscience>> Seizure Disorders>>1-Carboxycyclohexaneacetic Acid

1-Carboxycyclohexaneacetic Acid (Synonyms: Gabapentin Impurity E, Gabapentin Related Compound E, NSC 90823)

Katalog-Nr.GC49861

A potential impurity in commercial preparations of gabapentin

Products are for research use only. Not for human use. We do not sell to patients.

1-Carboxycyclohexaneacetic Acid Chemische Struktur

Cas No.: 67950-95-2

Größe Preis Lagerbestand Menge
5 mg
88,00 $
Auf Lager
10 mg
157,00 $
Auf Lager
50 mg
349,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

1-Carboxycyclohexaneacetic acid is a potential impurity in commercial preparations of the antiepileptic gabapentin.1 It has also been used as a precursor in the synthesis of antagonists of the serotonin (5-HT) receptor subtype 5-HT2A.2

1.Ragham, P.K., and Chandrasekhar, K.B.Development and validation of a stability-indicating RP-HPL C-CAD method for gabapentin and its related impurities in presence of degradation productsJ. Pharm. Biomed. Anal.125122-129(2016) 2.Obniska, J., Pawlowski, M., Kolaczkowski, M., et al.Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dionePol. J. Pharmacol.55(4)553-557(2003)

Bewertungen

Review for 1-Carboxycyclohexaneacetic Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1-Carboxycyclohexaneacetic Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.